2016
DOI: 10.1016/j.drudis.2016.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery

Abstract: Engineered in vitro models using human cells, particularly patient-derived induced pluripotent stem cells (iPSCs), offer a potential solution to issues associated with the use of animals for studying disease pathology and drug efficacy. Given the prevalence of muscle diseases in human populations, an engineered tissue model of human skeletal muscle could provide a biologically accurate platform to study basic muscle physiology, disease progression, and drug efficacy and/or toxicity. Such platforms could be use… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
42
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(42 citation statements)
references
References 114 publications
0
42
0
Order By: Relevance
“…Through development of nanotopographical substrates, a novel disease model for Duchenne muscular dystrophy has been discovered [72, 73]. By using patient specific hiPSCs, this particular model can more accurately test disease phenotypes without the effort of in vivo testing.…”
Section: Biophysical Regulation Of Cell Reprogrammingmentioning
confidence: 99%
“…Through development of nanotopographical substrates, a novel disease model for Duchenne muscular dystrophy has been discovered [72, 73]. By using patient specific hiPSCs, this particular model can more accurately test disease phenotypes without the effort of in vivo testing.…”
Section: Biophysical Regulation Of Cell Reprogrammingmentioning
confidence: 99%
“…Conversely, directed differentiation approaches have employed several methodologies, each aimed at recapitulating the early differentiation stages that take place in the embryo to generate skeletal muscle (Table S2). Reviews of the field have so far been mostly comparative, focusing on the different methods used to generate skeletal muscles in vitro and their relative success (Abujarour and Valamehr, 2015;Baker and Lyons, 1996;Smith et al, 2016). In the following sections, we will discuss these studies in the context of developmental and cell biology and consider the extent to which they recapitulate in vivo myogenesis.…”
Section: Skeletal Myogenesis In the Dish: Learning From Developmentmentioning
confidence: 99%
“…[96] Similar studies studying disease onset in other engineered tissues and organoids, such as skeletal muscle, brain, gut, kidney, and liver, have likewise contributed significantly to the scientific community's understanding of biological design principles. [97][98][99] …”
Section: Environmental Feedback and Adaptation In Engineered Biologicmentioning
confidence: 99%